Drugline is a fortnightly electronic drug bulletin for health professionals.
Scroll

Drugline

Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

Tafamidis on the PBS

Drugline Volume 497

Tafamidis is now available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM). This condition is associated with the accumulation of misfolded transthyretin in the myocardium,…

Read more

Novel Therapy for Hypertrophic Cardiomyopathy

Drugline Volume 496

Mavacamten is now available on the Pharmaceutical Benefits Scheme (PBS) to treat symptomatic obstructive hypertrophic cardiomyopathy. Mavacamten is a novel drug that acts as a selective and reversible inhibitor of cardiac myosin. It reduces…

Read more

New Medication for Hot Flushes

Drugline Volume 495

The neurokinin-3 receptor antagonist, fezolinetant, is now available for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. This is the first non-hormonal medication approved for this indication. The physiology of…

Read more

Inclisiran on the PBS

Drugline Volume 494

Inclisiran was recently added to the Pharmaceutical Benefits Scheme (PBS) as a third-line option for non-familial hypercholesterolaemia and familial heterozygous hypercholesterolaemia. Inclisiran is a first-in-class therapy known as a small interfering ribonucleic acid (siRNA)….

Read more

Expanded PBS Listing for Dapagliflozin

Drugline Volume 493

The Pharmaceutical Benefits Scheme (PBS) listing for dapagliflozin has recently been expanded. It is now subsidised for the treatment of heart failure independent of left ventricular ejection fraction (LVEF). When used for the management…

Read more

Cephalosporin-induced Neurotoxicity

Drugline Volume 492

The product information documents of many cephalosporin products have recently been updated to include warnings of neurotoxicity. Cephalosporins are broad-spectrum beta-lactam antibiotics that are commonly used to treat a range of infections. Neurotoxicity has…

Read more
Load More

April 2024

February 2024

January 2024

November 2023

February 2023

September 2022

August 2022

April 2022

February 2022

December 2021

November 2021

October 2021

August 2021

Post-injection Syndrome (Aug. 20 2021)

Alirocumab on the PBS (Aug. 06 2021)

May 2021

April 2021

PBS Changes for Adalimumab (Apr. 30 2021)

Short-course Oxycodone (Apr. 16 2021)

March 2021

January 2021

December 2020

November 2020

October 2020

September 2020

July 2020

May 2020

March 2020

December 2019

November 2019

October 2019

New Warning for Febuxostat (Oct. 18 2019)

Naloxone Nasal Spray (Oct. 04 2019)

April 2019

New High-Strength Insulin (Apr. 18 2019)

Tofacitinib Safety Issue (Apr. 05 2019)

March 2019

February 2019

January 2019

December 2018